Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: A retrospective study of the Surveillance, Epidemiology and End Results (SEER) database

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wang, Jun ^a,b   Mittendorf, Elizabeth A ^b   Sahin, Aysegul A ^b   Yi, Min ^b   Caudle, Abigail ^b   Hunt, Kelly K ^b   Wu, Yun ^b  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE DISSECTION; TREATMENT OUTCOME; VERY ELDERLY; AXILLA; BREAST TUMOR; CANCER REGISTRY; LUNG CARCINOMA; LYMPH NODE; LYMPHATIC METASTASIS; PATHOLOGY; PROCEDURES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL; TUMOR INVASION; UNITED STATES;

AXILLA; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84896105029     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089778     Document Type: Article

References (16)

1. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, et al. (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305: 569-575.
2. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252: 426-432.
3. Tavassoli FA, Devilee P (2003) Pathology and genetics. In tumors of the breast and female genital organs. WHO classification of tumors series. Lyon: IARC press.pp. 23-26.
4. Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, et al. (2008) International Breast Cancer Study Group. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 26: 3006-3014.
5. Stephen BE, David RB, Michael A, eds. (2010) AJCC Cancer Staging Manual. 7th ed. New York: Springer. pp. 355.
6. Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, et al. (2006) Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 192: 552-555. (Pubitemid 44344191)
7. Peiro G, Bornstein BA, Connolly JL, Gelman R, Hetelekidis S, et al. (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59: 49-54. (Pubitemid 30153897)
8. Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, et al. (2011) Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 29: 3885-3891.
9. Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, et al. (2010) Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol 17: 343-351.
10. Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, et al. (2009) Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27: 2946-2953.
11. Leitch A, McCall L, Beitsch P, Whitworth P, Reintgen D, et al. (2006) Factors influencing accrual to ACOSOG Z0011, a randomized phase III trial of axillary dissection vs. observation for sentinel node positive breast cancer. J Clin Oncol 24: 601.
12. Reznik J, Cicchetti MG, Degaspe B, Fitzgerald TJ (2005) Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys 61: 163-168. (Pubitemid 40039118)
13. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, et al. (2011) Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol 18: 2407-2412.
14. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS (1993) The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 5: 278-283. (Pubitemid 24009003)
15. Ribeiro GG, Dunn G, Swindell R, Harris M, Banerjee SS (1990) Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol (R Coll Radiol) 2: 27-34.
16. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, et al. (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74: 987-1001.